Abeona Therapeutics (ABEO) Analyst & Key Data

Analyst Consensus

Buy3 analysts

Buy

Updated Sep 12, 2026

Total Analysts3

Buy

6

Hold

3

Ratings

Updated Sep 12, 2026

Overall Rating

C

DCF Score3.0 / 5

Debt / Equity Score3.0 / 5

Price / Book Score2.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$5.42

Median Target+226.32%

$17.67

Potential upside vs current price

DCF Value-81.51%

$1.00

Potential downside vs current price

Current Stock Price

$5.42

Median Target+226.32%

$17.67

Potential upside vs current price

DCF Value-81.51%

$1.00

Potential downside vs current price

Analyst Consensus

Buy3 analysts

Buy

Updated Sep 12, 2026

Total Analysts3

Buy

6

Hold

3

Ratings

Updated Sep 12, 2026

Overall Rating

C

DCF Score3.0 / 5

Debt / Equity Score3.0 / 5

Price / Book Score2.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$5.42

Median Target+226.32%

$17.67

Potential upside vs current price

DCF Value-81.51%

$1.00

Potential downside vs current price

Current Stock Price

$5.42

Median Target+226.32%

$17.67

Potential upside vs current price

DCF Value-81.51%

$1.00

Potential downside vs current price

Abeona Therapeutics Inc.